Immunohistochemistry revealed only weak upregulation of DNA damage markers (γ‐H2AX) due to HMGA1 interference alone, but olaparib treatment led to significant DNA damage in tumours with HMGA1 knockdown (Figure 7E,F). The gene discussed is HMGA1; the disease is neoplasm.